Yintoni i-Vitamin D Dose efanelekileyo?
Ubungqina besayensi bubonisa ubungqina obuqinileyo phakathi kobunzima be-vitamin D kunye ne-multiple sclerosis (MS). Enyanisweni, uphando lubonisa ukuba ukungabikho kwe-vitamin D kunokubangela umngcipheko wokuphuhlisa i-MS ,
Esinye sezikhokelo eziphosakeleyo kule nxu lumenezelo lwe-MS. I-multiple sclerosis ininzi kakhulu kwiindawo ezisenyakatho, apho kukho ukukhanya kwelanga kakhulu kunye nezulu lezulu.
Ekubeni imizimba yethu ikhiqiza i-vitamin D ukusuka kwi-ray yelanga ye-ultraviolet, ukukhanya kancinci kwelanga kunokukhokelela ekunqongopheni kwe-vitamin D.
Ukongezelela, uphando lubonise ukuba i-vitamin D inokudlala indima kwindlela umntu ophumelelayo ngayo. Ngokomzekelo, i-vitamin D ifunyenwe ukunciphisa i-MS kwakhona.
Kukho ubungqina obuqinileyo bokuthi i-vitamin D, ingakumbi xa ithathwa nge-calcium, inokukunceda ukukhusela i- osteoporosis , isifo se-bone weakening esiqhelekileyo kubantu abane-MS. Ngako oko, ukuthintela i-osteoporosis kunye nekhefu lokuphumla kwamathambo ngowenye inzuzo enokufumaneka kwe-vitamin D kwi-MS
Ukongezwa ngeVithamini D e-MS
Ngokusekelwe kwikhonkco phakathi kwe-vitamin D kunye ne-MS, akumangalisi ukuba amaninzi amaninzi e-neurologists ahlola amanqanaba e-vitamin D kunye / okanye ancoma i-vitamin D yokuxhaswa kwizigulane zabo. Oko kuthethwa, okwangoku akukho mkhombandlela oqhelekileyo ochaza ngokucacileyo ukuba isilinganisi "esiqhelekileyo" se-vitamin D yintoni kunye nokuba kufuneka umntu athathe ntoni ngokusekelwe kuloo nqanaba.
Oko kuthetha, i-Institute of Medicine ibike ukuba i-vitamin D (25OHD) eyi-50nmol / L okanye ngaphezulu "inelisekile." Iingcali ze-neurologists eziphatha i-MS nangona zifuna amazinga e-vitamin D aphakamileyo, afana ne-75 ukuya kwi-125mol / L.
Iimpawu ze-Vitamin D zokuzikhethela
Ukuba ugqirha wakho uncoma i-vitamin D yokuxhaswa, mhlawumbi uya kubala idosi yakho esekelwe kwizinga lakho levithamini D, apho uhlala khona, kunye nexesha lonyaka-ungadinga i-vitamin D ngaphezulu kwinyanga zasebusika xa kunokukhanya kwelanga.
Nangona kungekho umthetho okhuni kunye onokukhawuleza, i-vitamin D ifowuni iphakathi kwe-1,000 IU kunye no-2,000 IU ka-vitamin D imihla ngemihla. Abanye oogqirha banokuphakamisa umthamo wemihla ngemihla ye-4000 IU imihla ngemihla. Ukuba izinga lakho le-vitamin D liphantsi kakhulu ukuqala, ugqirha wakho unokumisela umthamo ophezulu, njengama-vithamini D engama-50 000 kwiiveki ezi-6 ukuya kweyesi-8, kunye ne-dose yemihla ngemihla, njenge-2000 IU.
Kwakhona, i-dosing iyatshintsha kakhulu ngeli xesha kwaye ilandelelaniswa nesigulane ngasinye.
Yintoni eyenzekayo Ukuba Uthatha i-Vitamin D kakhulu
Isiphumo esisisiseko se-vitamin D isifo soxinzelelo se-hypercalcemia, oko kuthetha ukuba kukho i-calcium eninzi kwigazi lakho. Imiqondiso kunye neempawu ze-hypercalcemia ziquka:
- Isihlunu kunye / okanye ukuhlanza
- Ukutshatyalaliswa kunye / okanye ukudideka
- Ukutyunjwa
- Ukukhathala
- Ukunciphisa ukutya
- Ubuthathaka
- Amatye eentso
Unyango lwe-vitamin D yetyhefu iyimisebe ye-vitamin D kunye nezinye iindlela zokuncedisa unyango ukuze uhlawule amanqanaba e-calcium egazini lakho.
ILizwi
Kukho konke, isihloko se-vitamin D kunye nokuxhaswa kwi-MS asikacaci ngokucacileyo ngeli xesha. Kufuneka kwenziwe uphando olungakumbi lwezenzululwazi ukuze kucaciswe indlela kwaye nini oogqirha kufuneka bajonge kwaye baphathe amazinga e-vitamin D kwi-MS. Kuwe, oku kuthetha ukuba kulungele ukuthatha i-vitamin D kuphela phantsi kwengqalelo yonyango wakho we-MS.
> Imithombo
> Alharbi FM. Ukuhlaziywa kwi-vitamin D kunye ne-multiple sclerosis. Neuroscience (Riyadh) . 2015 Oct; 20 (4): 329-35.
> Bowling AC. National Society of MS. I-Vitamin D kunye ne-MS: Impembelelo yeZenzo zoKliniki.
> Hathcock JN, Shao A, Vieth R, Heaney R. Uvavanyo lwengozi lwe vithamini D. Am J Clin Nutrition. 2007 Jan; 85 (1): 6-18.
> Heaney, RP. I-Vitamin D: iimpawu zokukhusela nokusebenza. Isisombululo seNutrition 2008. I-Oct; 66 (10 iSiza 2): S178-81.
> USimon KC, u-Munger KL, u-Ascherio A. I-Vitamin D kunye ne-multiple sclerosis: i-epidemiology, i-immunology, ne-genetics. Curr Opin Neurol . 2012 Juni; 25 (3): 246-51.